IP Library Granted Patent US 12,268,695
Granted Patent B2
US 12,268,695 · App. 18/492,536 · Granted Apr 8, 2025

Betulin-containing birch bark extracts and their formulation

Inventors: John Ashleigh Watson (Walenstadt, CH); Sebastian Jäger (Wiernsheim, DE); Tobias Zahn (Pforzheim, DE)
Assignee: Amryt Pharmaceuticals Designated Activity Company
A61K31/56A61K31/045A61K36/185A61L15/44A61L26/0066A61K9/0014A61K9/06A61K9/107A61K9/122A61K45/06A61K2236/00A61L2300/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,268,695
App. No.
18/492,536
Granted
Apr 8, 2025
Kind
B2
Abstract

The present disclosure relates to birch bark extracts, methods of producing such extracts, stable pharmaceutical compositions containing such extracts and methods of using of such extracts. The birch bark extracts of the present disclosure contain triterpenes, which are known to improve wound healing.

Claims (43)

1. A method of treating a wound associated with epidermolysis bullosa in a patient in need thereof, comprising topically administering a sterile oleogel to the wound,

wherein the oleogel comprises about 1 wt. % to about 20 wt. % of particles of a solid birch bark extract dispersed in one or more nonpolar liquids;

wherein the solid birch bark extract comprises at least about 70 wt. % betulin and one or more triterpenes selected from the group consisting of betulinic acid, oleanolic acid, erythrodiol, and lupeol; and

wherein the oleogel is sterilized by ionizing irradiation at doses ranging from about 11 to about 40 kGy.

2. The method of claim 1 , wherein the oleogel has a consistency ranging from about 300-3000 mN; wherein the consistency is the force (mN) needed to penetrate 1 cm into the oleogel as measured using a texture analyser with a 1.27 cm cylindrical penetrating object, and the speed of penetration is 0.4 mm/s.

3. The method of claim 1 , wherein the oleogel is prepared by a process comprising dispersing the about 1 wt. % to about 20 wt. % of a dried solid birch bark extract in the one or more non-polar liquids; and wherein the nonpolar liquid has a peroxide value less than about 3.

4. The method of claim 1 , wherein the oleogel is sterilized by ionizing irradiation at doses ranging from about 11 to about 20 kGy.

5. The method of claim 1 , wherein the ionizing radiation is X-ray or gamma radiation.

6. The method of claim 1 , wherein the dispersed solid birch bark extract particles are the only oleogel forming agent in the oleogel.

7. The method of claim 1 , wherein the oleogel comprises about 10 wt. % of particles of the solid birch bark extract.

8. The method of claim 1 , wherein the nonpolar liquid comprises one or more vegetable oils.

9. The method of claim 8 , wherein the nonpolar liquid is sunflower oil.

10. The method of claim 1 , wherein the oleogel is substantially free of solid birch bark extract particles having a size greater than about 50 μm.

11. A method of treating a wound associated with epidermolysis bullosa in a patient in need thereof, comprising:

(a) applying a sterile oleogel to the surface of a dressing and

(b) contacting the wound with the dressing such that the oleogel is in direct contact with the wound;

wherein the sterile oleogel comprises about 1 wt. % to about 20 wt. % of particles of a solid birch bark extract, dispersed in one or more nonpolar liquids;

wherein the solid birch bark extract comprises at least about 70 wt. % betulin and one or more triterpenes selected from the group consisting of betulinic acid, oleanolic acid, erythrodiol, and lupeol; and

wherein the oleogel is sterilized by ionizing irradiation at doses ranging from about 11 to about 40 kGy.

12. The method of claim 11 , wherein the oleogel has a consistency ranging from about 300-3000 mN; wherein the consistency is the force (mN) needed to penetrate 1 cm into the oleogel as measured using a texture analyser with a 1.27 cm cylindrical penetrating object, and the speed of penetration is 0.4 mm/s.

13. The method of claim 11 , wherein the oleogel is prepared by a process comprising dispersing the about 1 wt. % to about 20 wt. % of a dried solid birch bark extract in the one or more non-polar liquids; and wherein the nonpolar liquid has a peroxide value less than about 3.

14. The method of claim 11 , wherein the oleogel is sterilized by ionizing irradiation at doses ranging from about 11 to about 20 kGy.

15. The method of claim 11 , wherein the ionizing radiation is X-ray or gamma radiation.

16. The method of claim 11 , wherein the dispersed solid birch bark extract particles are the only oleogel forming agent in the oleogel.

17. The method of claim 11 , wherein the oleogel comprises about 10 wt. % of particles of the solid birch bark extract.

18. The method of claim 11 , wherein the nonpolar liquid comprises one or more vegetable oils.

19. The method of claim 18 , wherein the nonpolar liquid is sunflower oil.

20. The method of claim 11 , wherein the oleogel is substantially free of solid birch bark extract particles having a size greater than about 50 μm.

21. A method of treating a wound associated with epidermolysis bullosa in a patient in need thereof, comprising:

(a) applying a sterile oleogel to the wound and

(b) covering the wound with a dressing;

wherein the sterile oleogel comprises about 1 wt. % to about 20 wt. % of particles of a solid birch bark extract, dispersed in one or more nonpolar liquids;

wherein the solid birch bark extract comprises at least about 70 wt. % betulin and one or more triterpenes selected from the group consisting of betulinic acid, oleanolic acid, erythrodiol, and lupeol; and

wherein the oleogel is sterilized by ionizing irradiation at doses ranging from about 11 to about 40 kGy.

22. The method of claim 21 , wherein the oleogel has a consistency ranging from about 300-3000 mN; wherein the consistency is the force (mN) needed to penetrate 1 cm into the oleogel as measured using a texture analyser with a 1.27 cm cylindrical penetrating object, and the speed of penetration is 0.4 mm/s.

23. The method of claim 21 , wherein the oleogel is prepared by a process comprising dispersing the about 1 wt. % to about 20 wt. % of a dried solid birch bark extract in the one or more non-polar liquids; and wherein the nonpolar liquid has a peroxide value less than about 3.

24. The method of claim 21 , wherein the oleogel is sterilized by ionizing irradiation at doses ranging from about 11 to about 20 kGy.

25. The method of claim 21 , wherein the ionizing radiation is X-ray or gamma radiation.

26. The method of claim 21 , wherein the dispersed solid birch bark extract particles are the only oleogel forming agent in the oleogel.

27. The method of claim 21 , wherein the oleogel comprises about 10 wt. % of particles of the solid birch bark extract.

28. The method of claim 21 , wherein the nonpolar liquid comprises one or more vegetable oils.

29. The method of claim 28 , wherein the nonpolar liquid is sunflower oil.

30. The method of claim 21 , wherein the oleogel is substantially free of solid birch bark extract particles having a size greater than about 50 μm.

Assignments (2)
MERGER Recorded Apr 29, 2024
From: AMRYT RESEARCH LIMITED
To: AMRYT PHARMACEUTICALS DESIGNATED ACTIVITY COMPANY
Reel/Frame 067257/0276 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2024
From: ZAHN, TOBIAS; WATSON, JOHN ASHLEIGH; JÄGER, SEBASTIAN
To: AMRYT RESEARCH LIMITED
Reel/Frame 067224/0263 →
Continuity (6)
Continuation 17686807 · Mar 4, 2022
Continuation 17393171 · Aug 3, 2021
Continuation 17120678 · Dec 14, 2020
Continuation 16959098
Provisional Application 62613646 · Jan 4, 2018
Related Publication 20240050445A1 · Feb 15, 2024
References Cited (174)
US 2764620A · Findlay · 1956 [cited by applicant]
US 3489690A · Lachampt et al. · 1970 [cited by applicant]
US 4044031A · Johansson et al. · 1977 [cited by applicant]
US 4265824A · Koskenniska et al. · 1981 [cited by applicant]
US 4481185A · Grollier et al. · 1984 [cited by applicant]
US 4732708A · Ekman et al. · 1988 [cited by applicant]
US 4933177A · Grollier et al. · 1990 [cited by applicant]
US 5166176A · Obagi et al. · 1992 [cited by applicant]
US 5248807A · Fujimoto et al. · 1993 [cited by applicant]
US 5466452A · Whittle · 1995 [cited by applicant]
US 5567419A · Togiya et al. · 1996 [cited by applicant]
US 5647976A · Rothe et al. · 1997 [cited by applicant]
US 5660727A · Gleave et al. · 1997 [cited by applicant]
US 5750578A · Carlson et al. · 1998 [cited by applicant]
US 5753493A · Wiersma · 1998 [cited by applicant]
US 5780196A · Fujiwara et al. · 1998 [cited by applicant]
US 5785856A · Gleave et al. · 1998 [cited by applicant]
US 5843311A · Richter et al. · 1998 [cited by applicant]
US 5882916A · Wiersma · 1999 [cited by applicant]
US 6008246A · Ito et al. · 1999 [cited by applicant]
US 6022890A · Bao et al. · 2000 [cited by applicant]
US 6124362A · Bradbury et al. · 2000 [cited by applicant]
US 6175035B1 · Draeger et al. · 2001 [cited by applicant]
US 6187323B1 · Aiache et al. · 2001 [cited by applicant]
US 6264998B1 · Ramadoss et al. · 2001 [cited by applicant]
US 6280778B1 · Gaudet et al. · 2001 [cited by applicant]
US 6342208B1 · Hyldgaard et al. · 2002 [cited by applicant]
US 6392070B1 · Krasutsky et al. · 2002 [cited by applicant]
US 6403816B1 · Jaggi et al. · 2002 [cited by applicant]
US 6682763B2 · Kuno et al. · 2004 [cited by applicant]
US 6746695B1 · Martin et al. · 2004 [cited by applicant]
US 7482383B2 · Scheffler · 2009 [cited by applicant]
US 7799352B2 · Nho et al. · 2010 [cited by applicant]
US 8536380B2 · Scheffler · 2013 [cited by applicant]
US 8828444B2 · Scheffler · 2014 [cited by applicant]
US 9352041B2 · Scheffler · 2016 [cited by applicant]
US 9827214B2 · Scheffler · 2017 [cited by applicant]
US 11083733B2 · Watson · 2021 [cited by examiner]
US 11266660B2 · Watson · 2022 [cited by examiner]
US 11826374B2 · Watson · 2023 [cited by examiner]
US 20010038878A1 · Bhaggan et al. · 2001 [cited by applicant]
US 20020119935A1 · Krasutsky et al. · 2002 [cited by applicant]
US 20020128210A1 · Krasutsky et al. · 2002 [cited by applicant]
US 20030087789A1 · Scheffler · 2003 [cited by applicant]
US 20030108624A1 · Kosbab · 2003 [cited by applicant]
US 20030124158A1 · Heidenfelder et al. · 2003 [cited by applicant]
US 20030133958A1 · Kuno et al. · 2003 [cited by applicant]
US 20040146477A1 · Meffert et al. · 2004 [cited by applicant]
US 20050019426A1 · Wirth et al. · 2005 [cited by applicant]
US 20070231418A1 · Scheffler · 2007 [cited by applicant]
US 20070299285A1 · Scheffler · 2007 [cited by applicant]
US 20090131714A1 · Krasutsky et al. · 2009 [cited by applicant]
US 20090166178A1 · Harmon et al. · 2009 [cited by applicant]
US 20120231054A1 · Scheffler · 2012 [cited by applicant]
US 20120315315A1 · Neubourg · 2012 [cited by applicant]
US 20140050790A1 · Scheffler · 2014 [cited by applicant]
US 20160317481A1 · Scheffler · 2016 [cited by applicant]
US 20180263937A1 · Scheffler · 2018 [cited by applicant]
US 20180296508A1 · Scheffler · 2018 [cited by applicant]
US 20190183797A1 · Daniels et al. · 2019 [cited by applicant]
US 20200330481A1 · Watson et al. · 2020 [cited by applicant]
US 20210093647A1 · Watson et al. · 2021 [cited by applicant]
US 20210369733A1 · Watson et al. · 2021 [cited by applicant]
US 20220184097A1 · Watson et al. · 2022 [cited by applicant]
CA 2385139A1 · 2001 [cited by applicant]
CN 101664562A · 2010 [cited by applicant]
CN 103439446A · 2013 [cited by applicant]
CN 107158156A · 2017 [cited by applicant]
DE 3207005A1 · 1982 [cited by applicant]
DE 4318280A1 · 1993 [cited by applicant]
DE 19544905A1 · 1997 [cited by applicant]
DE 10056902A1 · 2002 [cited by applicant]
DE 10317400A1 · 2004 [cited by applicant]
DE 10329955A1 · 2005 [cited by applicant]
DE 19713768B4 · 2006 [cited by applicant]
EP 1410790A1 · 2004 [cited by applicant]
EP 1526906A1 · 2005 [cited by applicant]
EP 1872788A1 · 2008 [cited by applicant]
ES 2279136T3 · 2007 [cited by applicant]
ES 2576832T3 · 2016 [cited by applicant]
JP S5742326A · 1982 [cited by applicant]
JP S597106A · 1984 [cited by applicant]
JP S5967212A · 1984 [cited by applicant]
JP S59206496A · 1984 [cited by applicant]
JP S61205204A · 1986 [cited by applicant]
JP H02169507A · 1990 [cited by applicant]
JP H054911A · 1993 [cited by applicant]
JP H0597106A · 1993 [cited by applicant]
JP H09235293A · 1997 [cited by applicant]
JP H10152444A · 1998 [cited by applicant]
JP 2002138014A · 2002 [cited by applicant]
JP 2003146865A · 2003 [cited by applicant]
JP 2003335627A · 2003 [cited by applicant]
JP 2004107227A · 2004 [cited by applicant]
JP 2004519411A · 2004 [cited by applicant]
JP 2008037871A · 2008 [cited by applicant]
JP 2009506981A · 2009 [cited by applicant]
JP 2017505298A · 2017 [cited by applicant]
RU 2635533C1 · 2017 [cited by applicant]
WO WO9832443A1 · 1998 [cited by applicant]
WO WO9834603A1 · 1998 [cited by applicant]
WO WO0062751A2 · 2000 [cited by applicant]
WO WO0103712A1 · 2001 [cited by applicant]
WO WO0110885A2 · 2001 [cited by applicant]
WO WO0119365A1 · 2001 [cited by applicant]
WO WO0172315A1 · 2001 [cited by applicant]
WO WO03043594A2 · 2003 [cited by applicant]
WO WO2004016336A1 · 2004 [cited by applicant]
WO WO2005123037A1 · 2005 [cited by applicant]
WO WO2006133395A2 · 2006 [cited by applicant]
WO WO2006135493A2 · 2006 [cited by applicant]
WO WO2008046541A2 · 2008 [cited by applicant]
WO WO2008055143A2 · 2008 [cited by applicant]
WO WO2009090394A2 · 2009 [cited by applicant]
WO WO2011064271A2 · 2011 [cited by applicant]
WO WO2011107522A2 · 2011 [cited by applicant]
WO WO2015104544A1 · 2015 [cited by applicant]
WO WO2017147067A1 · 2017 [cited by applicant]
WO WO2018017576A1 · 2018 [cited by applicant]
WO WO2019134982A1 · 2019 [cited by applicant]
Amryt Pharma: “Phase III Efficacy and Safety Study of Oleogei-S10 in Epidermolysis Bullosa”, ClinicaiTrials.gov, Sep. 22, 2022 (Sep. 22, 2022), XP055983106, Retrieved from the Internet: URL: https://clinicaltrials.gov/c… [cited by applicant]
Atherton et al, “Epidermolysis Bullosa: An outline for professionals.” Great Ormond Street Hospital for Children, London, England, Nov. 2003, 1 page. [cited by applicant]
Barret, J.P., “Accelerated re-epithelialization of partial-thickness skin wounds by a topical betulin gel: Results of a randomized phase III clinical trials program.” Burns (Sep. 2017); 43(6): 1284-1294. Epub Apr. 8, 20… [cited by applicant]
Broughton II, et al., “Wound Healing: An Overview.” Plastic and Reconstructive Surgery (Jun. 2006); 117: 1e-S-4eS, 4 pages. [cited by applicant]
Castro and Robles, “Procesamiento y caracterización del gel de Aloe vera para la elaboración de hidrogeles, [Processing and characterization of Aloe vera gel for the production of hydrogels].” 2007. Instituto Peruano de… [cited by applicant]
Castro, et al., “Descontaminacion por radiacion gamma y caracterizacion de un gel de Aloe vera: Reporte Preliminar [Decontamination by gamma radiation and characterization of a gel of Aloe vera: Preliminary Report]”, In… [cited by applicant]
Committee for Proprietary Medicinal Products (CPMP): “Decision Trees for the Selection of Sterilisation Methods Annex to Note for Guidance on Development Pharmaceutics (CPMP/QWP/155/96) Discussion in the Quality Working… [cited by applicant]
Daniels, et al., “Betulin fur tensidfreie Emulsionen, [Betulin for surfactant-free emulsions]”, Pharmazeutische Zeitung, Govi Verlag, Eschborn, DE, vol. 153, No. 13, Mar. 1, 2008 (Mar. 1, 2008), pp. 34-35, ISSN: 0031-71… [cited by applicant]
Del Carmen Recio, M., et al., “Investigations on the steroidal anti-inflammatory activity of triterpenoids from Diospyros leucomelas,” Planta Med. 61: 9-12, (1995), 4 pages. [cited by applicant]
Eckermann, C., et al., “Comparison of solvents for extraction and crystallization ofbetulinol from birch bark waste,” Paperi ja Puu—Papper och Tra 3: 100-106, (1985). [cited by applicant]
Ekman, R., “Lipophilic Extractives of the Inner Bark of Birch, Betula verrucosa Ehrh.,” Finn. Chem. Letters, p. 162, (1983b). 4 pages. [cited by applicant]
Ekman, R., “The Suberin Monomers and Triterpenoids from the Outer Bark of Betula verrucosa Ehrh.,” Holzforschung, 37: 205-211, (1983a). 7 pages. [cited by applicant]
European Medicines Agency. Science Medicines Health, Assessment Report, Episalvan, Nov. 19, 2015, EMA/833320/2015, 104 pages. [cited by applicant]
Evers, M. et al., “Betulinic acid derivates: a new class of human immunodeficiency virus type 1, specific inhibitors with a new mode of action.” J. Med. Chem. 39: 1056-1068 (1996). [cited by applicant]
Extended European Search Report for EP Application No. 17831691.5, dated Dec. 11, 2019, 7 pages. [cited by applicant]
Extended European Search Report for European Application No. EP23173906.1 dated Oct. 26, 2023, 12 pages. [cited by applicant]
Färber and Daniels, “Ex vivo Skin Permeation of Betulin from Water-in-Oil Foams.” Skin Pharmacol Physiol. (2016); 29(5): 250-256. Epub Sep. 16, 2016. [cited by applicant]
German Office Action issued in Patent Application No. 11246367, dated Sep. 9, 2010; 4 pages (English translation). [cited by applicant]
Grysko, M. et al. (2013) “Evaluation of the mechanism of gelation of an oleogel based on atriterpene extract from the outer bark of birch.” Pharmazie, 68: 572-577. [cited by applicant]
Harish, B.G., et al. (2008) “Wound Healing activity and docking of glycogen-synthasekinase-3—protein with isolated triterpenoid Lupeol in rats.” Phytomedicine, 15: 763-767. [cited by applicant]
Hausmann, U., “Beiträge zur Kenntnifs des Betulins. Auszug aus Verfassers Inaugural Dissertation, Gttingen 1876 [On betulin. Excerpt from the author's Ph.D thesis, Gttingen 1876].” Annalen der Chemis, 182: 368-380 (with… [cited by applicant]
Hayek, E.W. et al., “A Bicentennial of Betulin.” Phytochemistry, 28(9): 2229-2242 (1989). [cited by applicant]
Hua, Y. et al., “Triterpenes From the Outer Bark of Betula Nigra,” Journal of Wood Chemistry and Technology 11 (4): 503-516 (1991). [cited by applicant]
Huneck, S., et al., “3β-Acetoxyhopan-1β,22-diol, a triterpene from the lichen Pseudoparmelia texana”, Phytochemistry, 22(9): 2027-2030, 1983. [cited by applicant]
Huyke Constance, et al: “Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot study.” J Dtsch Dermatol Ges. Feb. 2009; 7(2): 128-133. [cited by applicant]
International Atomic Energy Agency (IAEA), “Manual on Radiation Sterilization of Medical and Biological Materials.” International Atomic Energy Agency Vienna, 1973. Available at: https://inis.iaea.org/collection/NCLColl… [cited by applicant]
International Patent Application No. PCT/EP2010/068157, International Search Report and Written Opinion (and English translation), dated Jan. 16, 2012, 22 pages. [cited by applicant]
International Patent Application No. PCT/US2017/042610, International Preliminary Report on Patentability, dated Jan. 22, 2019, 7 pages. [cited by applicant]
International Patent Application No. PCT/US2017/042610, International Search Report and Written Opinion, mailed Oct. 2, 2017, 9 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/EP2019/050186, mailed Mar. 29, 2019, 17 pages. [cited by applicant]
Jaeger, et al., “Pharmakologie ausgewhlter Terpene.” In: Pharmazeutische Zeitung, 2006, vol. 151, S. 16-25. (German). [cited by applicant]
Jäger Sebastian and Zahn Tobias: “The new wound healing drug EPISALVAN: formulation and study design Das neue Wund-Arzneimittel Episalvan®: Galenik und Studiendesign.” PHARMAKON, vol. 4, No. 4, Jul. 2016, pp. 349-355, w… [cited by applicant]
Jääskeläinen, P., “Betulinol and its utilisation,” Paperi ja Puu—Papper och Tr 10: 599-603, (1981). [cited by applicant]
Lasczyk, Melanie (2007) “Triterpentrockenextrakt aus Birkenkork (Betula alba cortex). Untersuchungen zur chemischen Zusammensetzung, Galenik, Penetration und pharmakologisch-biologischen Wirkung.” Albert Ludwig Universi… [cited by applicant]
Laszczyk, M. et al. (2006) “Physical, Chemical and Pharmacological Characterization of a New Oleogel-Forming Triterpene Extract from the Outer Bark of Birch (Betulae Cortex).” Planta Med, 72(15): 1389-1395. [cited by applicant]
Laszczyk, M. et al. (2009) “Topical therapy with the betulin based triterpene extract (TE) in patients with chronic pruritus” Presented at the 57th International Congress and Annual Meeting of the Society for Medicinal … [cited by applicant]
Lowitz, M., “On a novel, almost benzoin-like, substance from birches,” Chemische Analysen, Hrsg. Grell, L., 2: 312 (and English translation), 5 pages. [cited by applicant]
Maquart, Francois-Xavier, et al., “Stimulation of Collagen Synthesis in Fibroblast Cultures by a Triterpene Extracted From Centella Asiatica”, Connective Tissue Research: An Internat. Healthcare, US, Bd, 24, Jan. 1, 199… [cited by applicant]
Nowak, G. A., “Cosmetic and Medicinal Properties of the Birch”, Amer. Perfumer Cosmet., 81: 37, (1966). 2 pages. [cited by applicant]
O'Connell, M.M. et al., “Betulin and Lupeol in Bark from four white-barked birches,” Phytochemistry 7: 2175-2176, (1988). [cited by applicant]
Pârvanescu et al., “Oleogel Formulations for the Topical Delivery of Betulin and Lupeol in Skin Injuries—Preparation, Physicochemical Characterization, and Pharmaco-Toxicological Evaluation,” Molecules, vol. 26, 4174, J… [cited by applicant]
Palla, Camila, et al., “Multi-objective optimization of high oleic sunflower oil and monoglycerides oleogels: Searching for rheological and textural properties similar to margarine.” Food structure 12 (2017): 1-14. [cited by applicant]
Schwieger-Briel, A, et al., “Betulin-Based Oleogel to Improve Wound Healing in Dystrophic Epidermolysis Bullosa: A Prospective Controlled Proof-of-Concept Study”, Dermatology Research and Practice, 2017, vol. 2017, Arti… [cited by applicant]
Shrikhande, B.K., et al. (Dec. 1, 2001) “Development and Evaluation of Antiinflammatory Oleogels of Bosewellia Serrate (GUGUL) and Curcuma longa (Turmeric).” Indian Drugs, Indian Drug Manufacturers Association; 38(12): … [cited by applicant]
Shukla, et al., “In vitro and in vivo wound healing activity of asiaticoside isolated from Gentelia asiatica”, Journal of Ethnopharmacology (1999); 65: 1-11. [cited by applicant]
Steinbrenner Isabel et al., “Influence of the Oil Phase and Topical Formulation on the Wound Healing Ability of a Birch Bark Dry Extract”, May 24, 2016, PLOS One, vol. 11, No., 5, e0155582, doi: 10.1371/journal.pone.015… [cited by applicant]
Sun, I-Chen, et al., “Anti-AIDS Agents, 32, Synthesis and anti-HIV activity of Betulin derivates,” Bioorganic & Medical Chemistry Letters 8: 1267-1272, (1998). [cited by applicant]
Tolstikov, et al., “Betulin and its derivatives, Chemistry and biological activity.” Chemistry for Sustainable Development (2005); 13: 1-29. [cited by applicant]
Ukkonen, K., et al., “Birch Bark Extractives,” Kemia-Kemi (1979); 5: 217-220. [cited by applicant]
Wheeler, “The Preparation of Betulin by Sublimation”, Pharmaceutical Journal (Nov. 1899); 494: 353, 1 page. [cited by applicant]
Yasukawa, K., et al., “Sterol and triterpene derivates from plants Inhibit the Effects of Tumor Promoter, and Sisterol and Betulinic Acid Inhibit Tumor Formation in Mouse Skin Two-Stage Carcinogenesis,” Oncogene 48: 72-… [cited by applicant]
Zahn, T., et al., “Birkenrindenextrakt zur Wundheilung”, Deutsche Apotheker Zeitung, Nov. 23, 2017 (Nov. 23, 2017), Retrieved from the Internet: URL: https://www.deutsche-apotheker-zeitung.de/daz-az/2017/daz-47-2017/bir… [cited by applicant]
Zhang et al., “Radiation Sterilization”, Traditional Chinese Pharmacy for the major of Chinese Materia Medica, New Century 2nd edition. China Press of Traditional Chinese Medicine, Mar. 2017. pp. 44, and English transla… [cited by applicant]
Zhao Guoling, et al: “Simultaneous determination of betulin and betulinic acid in white birch bark using RP-HPLC”, Journal of Pharmaceutical and Biomedical Analysis, 2007, vol. 43, pp. 959-962. [cited by applicant]